IPSOGEN
Ipsogen is develops and markets diagnostic tests in the field of oncology worldwide. The company offers diagnostic kits and biomarkers. Its products are used in the diagnosis, prognosis, and monitoring of patients with leukemia.
IPSOGEN
Industry:
Biotechnology Health Care Health Diagnostics Life Science
Founded:
1999-01-01
Address:
Marseille, Provence-Alpes-Cote D'Azur, France
Country:
France
Total Employee:
51+
Status:
Active
Contact:
+33 4 91 29 30 90
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Font Awesome ReCAPTCHA COVID-19 Vimeo MediaElement.js Varnish Adobe Dynamic Tag Management Disqus
Similar Organizations
CardioGenics
CardioGenics develops sensitive diagnostic test products to the IVD market.
Cytofind Diagnostics
Cytofind Diagnostics develops unique technology in the field of oncology diagnostics to improve outcomes & quality of life.
g-Nostics
G-Nostics develops diagnostic treatments and tests for individuals undergoing drug rehabilitation.
HepQuant
HepQuant develops minimally invasive diagnostics for liver function.
Immumed GmbH
Immumed GmbH operates as a development and service company for medical diagnostic problems in the field of immunology.
Investors List
Octalfa
Octalfa investment in Venture Round - Ipsogen